Novo and UCPH-researchers achieve positive results with potential obesity treatment

Researchers from Novo Nordisk and University of Copenhagen achieved promising pre-clinical results with an experimental drug that could potentially beat Novo's popular obesity treatment, Saxenda.

Photo: /Ritzau Scanpix/Jens Nørgaard Larsen

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles